Skip to main content

Table 1 Clinical characteristics of the patients

From: The study of the association between immune monitoring and pneumonia in kidney transplant recipients through machine learning models

Characteristics All (n = 146) Pneumonia (n = 46) Stable (n = 100) P value
Age, years ± SD 40.61 ± 10.04 41.52 ± 8.01 40.19 ± 10.57 0.458
Male, n (%) 83 (56.8) 27 (58.7) 56 (56.0) 0.760
Donor, n (%) 0.098*
 DCD 144 (98.6) 44 (95.7) 100 (100)  
 Relative 2 (1.4) 2 (4.3) 0 (0)  
Time since transplant (months) 11.67 ± 11.15 14.67 ± 15.24 10.33 ± 8.47 0.732#
Induction, n (%)  < 0.001*
 None 17 (11.6) 5 (10.9) 12 (12.0)  
 ATG 106 (72.6) 22 (47.8) 84 (84.0)  
 Basiliximab 7 (4.8) 3 (6.5) 4 (4.0)  
 NA 16 (11.0) 16 (34.8) 0 (0)  
eGFR (ml/min/1.73 m2) 71.31 ± 23.93 59.11 ± 24.62 76.92 ± 21.50  < 0.001
CNI, n (%) 0.742*
 FK506 135 (92.5) 42 (91.3) 93 (93.0)  
 CsA 11 (7.5) 4 (8.7) 7 (7.0)  
  1. Estimated glomerular filtration rate (eGFR) calculated by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation
  2. SD standard deviation, DCD donation after citizens' death, ATG anti-thymocyte globulin, NA not available, CNI calcineurin inhibitor, CsA cyclosporine A
  3. * Tested by Fisher’s exact test; # Tested by Mann–Whitney U test